🇺🇸 FDA

Drug profile · INN

sitagliptin phosphate

SITAGLIPTIN PHOSPHATE

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

sitagliptin phosphate (SITAGLIPTIN PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: film coated. Current US regulatory status: approved.

Key facts

INN sitagliptin phosphate
Brand SITAGLIPTIN PHOSPHATE
Route FILM COATED
Formulation TABLET, EXTENDED RELEASE
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 8329696

    Solid state forms of sitagliptin salts

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8183373

    Solid state forms of sitagliptin salts

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sitagliptin phosphate?

sitagliptin phosphate (SITAGLIPTIN PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: film coated. Current US regulatory status: approved.

What is the brand name for sitagliptin phosphate?

SITAGLIPTIN PHOSPHATE is a marketed brand name for sitagliptin phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sitagliptin phosphate?

sitagliptin phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.